810 results about "Chemiluminescence" patented technology

The invention discloses an anti-human hepatitis B e antigen monoclonal antibody and application thereof, and relates to the technical field of hepatitis B detection. In a heavy chain variable region of the monoclonal antibody, an amino acid sequence of a complementarity determining region CDR1-3 is as shown in SEQ ID NO.1-3 or has at least 95% of homology with the sequence as shown in SEQ ID NO.1-3; in the light chain variable region, amino acid sequences of complementary determining regions CDR1 and CDR3 are shown as SEQ ID NO.4 and SEQ ID NO.5 or have at least 95% of homology with the sequences shown as SEQ ID NO.4 and SEQ ID NO.5, and an amino acid sequence of a complementary determining region CDR2 is FAS. The monoclonal antibody provided by the invention can well recognize a natural hepatitis B e antigen, and the titer of a supernatant cultured by a B cell can reach 1: 10000, so that the monoclonal antibody can be completely applied to detection research of the human hepatitis B e antigen. The chemiluminescence reagent prepared by using the monoclonal antibody has the advantages of high specificity, strong anti-interference capability, high detection sensitivity, good stability and the like, almost has no leak detection, and can replace an imported reagent.

The present invention relates to the technical field of signal processing and fault diagnosis. The method of the present invention comprises: collecting a flame chemiluminescence signal, and performing adaptive filtering noise reduction processing; using an improved proper orthogonal decomposition method and a high-order mode to obtain comprehensive combustion feature information; developing a real-time synchrosqueezing transform algorithm to perform time-frequency analysis on data, and updating energy distribution in real time; taking into account sensor data to perform multi-parameter joint analysis to obtain a combustion state evaluation, using a plurality of high-speed cameras to acquire flame images from different angles, reconstructing three-dimensional flame morphology by means of a computer vision technology, and providing fault detection information; and constructing a fault prediction model to give an early warning of a combustion fault. The present method implements nondestructive and rapid detection of oscillating combustion faults, keeps rich information of flame images, reflects overall flame pulsation characteristics, increases the speed and accuracy of detection, and compensates for the defect of low frequency resolution of conventional time-frequency analysis methods.

Hydrogen-bonded framework nanoparticles comprising a chemiluminescent compound (e.g., L-012) are provided and can be used, e.g., for sono-optogenetic treatment of neurodegenerative diseases such as Parkinson's disease. Related in vivo and therapeutic methods are also provided.

The invention belongs to the technical field of immunodetection, and discloses an anti-T3 antibody mAb32 or an antigen binding fragment, the anti-T3 antibody mAb32 or the antigen binding fragment comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3, the amino acid sequence of the LCDR1 is shown as SEQ ID NO.1, the amino acid sequence of the LCDR2 is IAS, and the amino acid sequence of the LCDR3 is shown as SEQ ID NO.3; the heavy chain variable region comprises HCDR1, HCDR2 and HCDR3, and the amino acid sequences of the HCDR1, the HCDR2 and the HCDR3 are respectively shown as SEQ ID NO. 4-6. When the anti-T3 antibody mAb32 is used for detecting a T3 standard antigen, the detection sensitivity is lower than 0.2 ng / ml, and when a clinical sample is detected through a magnetochemiluminescence method, the correlation with R clinical comparison is good within the sample range of 1-80 pmol / L.

This invention discloses a monoclonal antibody against human hepatitis B e antigen and its application, relating to the field of hepatitis B detection technology. In the heavy chain variable region of the monoclonal antibody, the amino acid sequences of the complementarity-determining regions (CDR1-3) are as shown in SEQ ID NO. 1-3 or have at least 95% homology with the sequences shown in SEQ ID NO. 1-3; in the light chain variable region, the amino acid sequences of the complementarity-determining regions (CDR1 and CDR3) are as shown in SEQ ID NO. 4 and 5 or have at least 95% homology with the sequences shown in SEQ ID NO. 4 and 5, and the amino acid sequence of the complementarity-determining region (CDR2) is FAS. The monoclonal antibody provided by this invention can effectively recognize natural hepatitis B e antigen, and the titer of the supernatant from B cell culture can reach 1:10000, making it fully applicable to the detection and research of human hepatitis B e antigen. The chemiluminescent reagent prepared using the monoclonal antibody described in this invention has advantages such as high specificity, strong anti-interference ability, high detection sensitivity, and good stability, with almost no missed detections, and can replace imported reagents.

The invention relates to the technical field of immunodetection and immunodiagnosis, in particular to a chemiluminescence substrate solution, a chemiluminescence detection kit and a detection method. The chemiluminescent substrate solution comprises a substrate solution 1, or comprises the substrate solution 1 and a substrate solution 2, the substrate solution 1 comprises sodium hydroxide, a surfactant and a blue light absorbent for absorbing blue light with the wavelength of 400-500 nm; the substrate solution 2 comprises inorganic acid and hydrogen peroxide. According to the application, the blue light absorbent is added into the chemiluminescent substrate liquid, so that blue light emitted by acridinium ester can be absorbed, a luminescent signal is reduced, and particularly, the luminescent value of a background caused by non-specific adsorption is reduced, so that the signal-to-noise ratio is increased.

The invention discloses a magnetic particle chemiluminiscence detection kit for human non-phosphorylated Tau217 protein and a preparation method of the magnetic particle chemiluminiscence detection kit. The kit comprises a micro magnetic particle coupled with a human non-phosphorylated Tau217 protein capture antibody, an acridinium ester labeled human non-phosphorylated Tau217 protein detection antibody, a human non-phosphorylated Tau217 protein calibration product and a quality control product. The direct chemiluminescence method established by the invention has the advantages of high sensitivity, strong specificity, accuracy, rapidness and short detection time, the detection result has higher accuracy and repeatability, and the kit can be used for various luminescence detection instruments.

The invention belongs to the technical field of immunodetection, and discloses an anti-T3 antibody mAb68 or an antigen binding fragment, the anti-T3 antibody mAb68 or the antigen binding fragment comprises a light chain variable region and a heavy chain variable region, the light chain variable region comprises LCDR1, LCDR2 and LCDR3, the amino acid sequence of the LCDR1 is shown as SEQ ID NO.1, the amino acid sequence of the LCDR2 is TAS, and the amino acid sequence of the LCDR3 is shown as SEQ ID NO.3; the heavy variable region comprises HCDR1, HCDR2 and HCDR3, and the amino acid sequences of the HCDR1, the HCDR2 and the HCDR3 are respectively shown as SEQ ID NO. 4-6. When the anti-T3 antibody mAb68 is used for detecting a T3 standard antigen, the detection sensitivity is lower than 0.2 ng / ml, a clinical sample is detected through a magnetochemiluminescence method, and the correlation with R clinical comparison is good within the sample range of 1-80 pmol / L.

The invention provides an anti-beta2-glycoprotein I antibody detection reagent and a chemiluminescence detection kit, and the anti-beta2-glycoprotein I antibody detection reagent comprises a biotin-labeled beta2-glycoprotein I antigen prepared by reacting biotin connected with an LPETG label with the beta2-glycoprotein I antigen under the catalytic action of Sortase A enzyme. The N terminal of the beta2-glycoprotein I antigen is labeled with the biotin with a specific label in a fixed point manner, all amino acid sequence regions (structural domains I-V) of the beta2-glycoprotein I antigen are not influenced, and meanwhile, the purity of a connection product is high, the difference between batches is small, and the method is suitable for large-scale production. The positive detection rate and the detection result accuracy of the anti-beta2-glycoprotein I antibody magnetic particle chemiluminescence detection kit can be improved, and the difference between batches can be reduced.

The invention provides an electrochemical luminescence MeHA microneedle patch and a preparation method and application thereof.The preparation method comprises the steps that hyaluronic acid is modified into methacrylated hyaluronic acid, MeHA solid powder is obtained after purification, and the MeHA solid powder is mixed with a photoinitiator to form a precursor solution; and pouring into a microneedle mold, centrifuging, drying and carrying out UV crosslinking to obtain the MeHA microneedle patch loaded with ABEI and glucose oxidase. Through the MeHA microneedle patch-SPE electrode integrated design, the integrated operation of skin interstitial fluid in-situ extraction-enzymatic reaction-electrochemical luminescence detection is realized, sample transfer is not needed, the interference of intermediate links is greatly reduced, the detection accuracy and efficiency are remarkably improved, and the device and the method are particularly suitable for clinical real-time monitoring scenes.

The invention provides a dilution buffer solution for chemiluminescence detection of a blood sample. The dilution buffer solution contains 0.05 to 1 weight percent of plasmin and 0.005 to 0.02 weight percent of a de-foaming agent. The dilution buffer solution provided by the invention can reduce the jump value phenomenon in chemiluminescence detection of a blood sample, especially a repeatedly frozen and thawed blood sample, so that a correct and reliable detection result is provided for clinic, and the clinical detection time can be saved.

The embodiment of the invention discloses a refrigerator bacterium detection method and system based on an optical fiber ATP sensor, and the method comprises the steps: mixing a sample in a to-be-detected area of a refrigerator with a reaction reagent to form a to-be-detected solution, injecting the to-be-detected solution into a microfluidic reaction tank of the optical fiber ATP sensor, enabling an ATP component and an enzyme reagent to generate a chemiluminescence reaction, and enabling an optical signal to enter a transmission optical fiber through focusing coupling; the optical signal is transmitted to a photoelectric detection unit through a transmission optical fiber to be converted into an electric signal, and the electric signal contains response dynamic information; carrying out multi-stage processing on the electric signal, and extracting a signal characteristic parameter representing the concentration of the ATP component; and finally, performing matching analysis on the signal characteristic parameters and preset data, determining an ATP component content value, querying corresponding relation data to generate a detection result containing bacteria quantity information, and outputting the detection result to a refrigerator matched display device in a visual form. The problems of long detection time, complicated operation, inconvenience in equipment, difficulty in in-situ real-time monitoring and the like in the existing refrigerator bacterium detection technology can be solved.

The invention relates to a preparation method of a microwave-assisted synthesized near-infrared electrochemical luminescence gold nanocluster and application of the gold nanocluster in miRNA (micro Ribonucleic Acid) detection. The preparation method comprises the following steps: under a stirring condition, adding a gold source and alkali into a Met solution to obtain a mixed solution, carrying out microwave irradiation reaction, and carrying out solid-liquid separation to obtain a Met-Au NCs solution; the preparation method comprises the following steps: activating a Met-Au NCs solution by using EDC and NHS, adding a DNA solution, mixing, and dialyzing to obtain a Met-Au NCs-DNA compound, namely the near-infrared electrochemical luminescence gold nanocluster. Compared with Au NCs prepared by a common mild method, the Met-stable Au NCs prepared by a microwave-assisted method has the advantage that the fluorescence and electrochemical luminescence efficiency at 835 nm is improved. The invention also provides a'signal closing 'ECL (electron cyclotron ligand) biosensor for high-sensitivity detection of the miRNA-107 (MicroRNA-107), and a method for detecting the miRNA-107 (MicroRNA-107). The sensor is simple to operate and good in repeatability, and has important scientific significance and application value for clinical early diagnosis of cancers.

The application relates to a microfluidic portable food safety analyzer, a machine core comprises a base, and a top shell, an optical acquisition module, a pressing assembly, a heating module and a centrifugal assembly which are arranged on the base, and the top shell covers the optical acquisition module, the heating module and the centrifugal assembly; the centrifugal assembly is arranged to bear a disc-type chip to be detected, the optical acquisition module is arranged to be close to a first preset position of the disc-type chip, and the heating module is arranged to be close to a second preset position of the disc-type chip. The chemiluminescence detection is realized, qualitative, semi-quantitative or full-quantitative detection can be realized, the detection sensitivity is wider, and the accuracy is higher; no complex optical path design is adopted, and the precision required by positioning is relatively reduced, so that the requirement of positioning precision is met, and a relatively large error of a detection result is avoided; the device is suitable for detecting the disc-type chip, and detection results of multiple items can be obtained at a time, so that the requirement of high throughput is met; the device has the advantages of simple structure, small overall size, light weight and the like, and is convenient to carry and maintain.

The invention discloses a full-automatic chemiluminiscence detection reagent for a porcine reproductive and respiratory syndrome virus N antibody and application of the full-automatic chemiluminiscence detection reagent, and belongs to the technical field of biology. The detection reagent comprises a serum diluent, a first reagent and a second reagent, the first reagent comprises magnetic particles coated with porcine reproductive and respiratory syndrome virus N protein; and the second reagent comprises an acridinium ester labeled anti-pig antibody. The kit can accurately detect the porcine reproductive and respiratory syndrome virus N antibody, is high in sensitivity, good in specificity, strong in interference resistance, high in precision, short in reaction time, simple to operate and automatic, provides material guarantee and technical support for prevention and control of porcine reproductive and respiratory syndrome, and has important significance.

The invention discloses an early diagnosis and early screening kit for joint detection of Parkinson's disease and application of the kit, and relates to the technical field of medical treatment. The kit is used for combined detection of three proteins, namely alpha synuclein (alpha-Syn), tyrosine 3-monooxygenase / tryptophan 5-monooxygenase activated protein zeta (YWHAZ) and myosin light chain 6 (Myl6), immunochromatography, chemiluminescence and other methods and a double-antibody sandwich method are adopted, the diagnosis efficiency of the YWHAZ protein is prominent, the AUC reaches 0.96, and the detection sensitivity is high. The AUC of Myl6 is 0.92, the AUC of alpha-Syn is 0.82, the joint detection AUC is up to 0.98, the kit is newly added with a time-resolved fluorescence immunochromatography technology, low-background and high-sensitivity detection is realized through a lanthanide-labeled antibody, the change of related protein expression level can be detected in the early stage of Parkinson's disease, early screening and diagnosis are realized, and the kit has the advantages of high specificity, joint detection up to 95%, high sensitivity, high sensitivity and the like. The joint detection reaches 96%, the operation is simple and convenient, and the sample requirement is low.

The invention discloses a chemiluminescent probe of a targeted A beta oligomer as well as a preparation method and application of the chemiluminescent probe. The structural general formula of the chemiluminescent probe of the targeted A beta oligomer is shown as I in the specification. According to the present invention, the chemiluminescence probe capable of specifically targeting the A beta oligomer is successfully constructed for the first time so as to achieve the early diagnosis and treatment of AD; an additional light source is not needed, and background signals caused by exciting light can be effectively reduced, so that the detection sensitivity is higher. The chemiluminescent probe targeting the A beta oligomer can promote selective oxygenation of beta amyloid protein through chemical excitation and neutralize toxicity of the A beta oligomer, has certain treatment potential and is expected to be developed into an effective method for treating amyloidosis. # imgabs0 #

Methods, kits and compositions of detecting analytes, typically analytes relevant to neurodegenerative diseases such as neurofilament light chain, in a sample are described herein using chemiluminescent labels. Solid supports, reagents, and compounds for use in these methods are also described. Typically, the methods involve specific assay formats which provide the requisite high resolution for detecting low concentrations of analytes in samples and may be used in positions of the healthcare ecosystem close to the patient. These methods, systems, and apparatuses may afford early detection and prognosis of a wide variety of neurodegenerative diseases such as Alzheimer's disease and multiple sclerosis.

The invention relates to the field of sensors, and discloses a solid electrolyte for ammonia gas detection, an electrochemical luminescence sensor, a preparation method and a detection method, and the solid electrolyte for ammonia gas detection comprises the following raw materials: a second electrolyte, a luminescent substance, an optional first electrolyte and an optional binder. The solid electrolyte for ammonia gas detection provided by the invention can realize ppb-level NH3 selective detection with high sensitivity, wide linear response range and low detection limit at room temperature for an electrochemical luminescence sensor for detecting ammonia gas. The electrochemical luminescence sensor for detecting the ammonia gas can be used for sensing the ammonia gas through a cyclic voltammetry method and a constant potential-luminescence technology, and ppb-level high-sensitivity and high-selectivity ammonia gas detection is realized.

The invention discloses an SVR combustion instability prediction method and system, and relates to the field of energy power and intelligent control, and the method comprises the steps: obtaining a fault combustion flame chemiluminescence signal, and generating a signal data set comprising a training data set and a test data set; establishing a support vector regression model based on the training data set; evaluating the support vector regression model by using the test data set, and adjusting according to an evaluation result to obtain a prediction model; using the prediction model to predict to-be-predicted sample data; the historical flame chemiluminescence signal data of the gas turbine under different working conditions are adopted as data input and can be used for predicting the working state of the gas turbine after a certain time delay, and the model can perform algorithm processing on the flame chemiluminescence signal measured by the gas turbine and predict the change trend of the future moment. The occurrence time of the unstable combustion can be predicted, and enough time is reserved for the control process of the unstable combustion.

The invention discloses a chemiluminescence heparin binding protein kit and a determination method thereof. The kit comprises reagent components of a reagent R1, a reagent R2 and a reagent R3, as well as a matched calibrator, a matched quality control product, a matched pre-excitation liquid, a matched excitation liquid and a matched cleaning liquid, wherein the reagent R1 contains magnetic particles coated with streptavidin, and the reagent R2 and the reagent R3 are respectively monoclonal antibodies which are labeled by acridinium ester and biotin and are used for recognizing different epitopes of human HBP. The kit shows better sensitivity, wider detection range and high specificity, and can effectively reduce potential endogenous and exogenous interference in clinical samples of potential interference people.

The invention discloses construction and application of a confinement enhanced photoelectrochemistry-electrochemiluminescence dual-mode biosensor, and relates to the technical field of biosensing and analytical chemistry. The preparation method of the biosensor comprises the following steps: taking a CdS (at) SiO2 (at) NaYF4: Yb / Tm nano composite material as a substrate to obtain a confinement enhanced photoelectrochemistry (PEC) and electrochemiluminescence (ECL) sensing interface; in combination with a DNA wheel nanostructure triggered by target acetamiprid, signal amplification is realized; and synchronous dual-mode quenching detection of PEC and ECL signals is realized by virtue of peroxidase-like catalytic precipitation and wide-spectrum absorption characteristics of the PtPd-CoSnO3 nanocube. The biosensor prepared by the invention has the advantages of high sensitivity, strong reliability, good selectivity and the like, can be applied to accurate detection of acetamiprid in samples such as agricultural products and the like, and has important application value in the aspects of environmental monitoring and food safety control.

The invention discloses a light-activated chemiluminescence method for detecting myxovirus resistant protein A, and belongs to the technical field of marker detection. The invention provides a detection system of a myxovirus resistance protein A. The detection system comprises an MxA Ab1-acceptor microsphere complex and an MxA Ab2-donor microsphere complex. The invention provides a detection system of myxovirus resistance protein A. The detection system is used for detecting MxA, is homogeneous and washing-free, is simple and convenient to operate and high in sensitivity, and has a wide linear range. Experiments prove that the detection limit of the myxovirus resistant protein A antigen is 1.37 ng / mL, and the linear range is 5-1229 ng / mL. The kit is high in specificity and repeatability, can be used for rapidly detecting virus infection markers, and has application value.

The invention discloses a magnetic porous microsphere for in-vitro diagnosis and a preparation method of the magnetic porous microsphere, and belongs to the technical field of preparation of micro-nano materials. According to the invention, styrene is used as a polymerization monomer, and a dispersion polymerization method is adopted to prepare monodisperse polystyrene microspheres; ferric chloride and ferrous sulfate are selected as precursors, magnetic nanoparticles are synthesized through a coprecipitation method under the alkaline condition, the initial loading capacity is changed, the magnetic nanoparticles are loaded on the surfaces and in pore channels of polymer porous microspheres through a multi-step seed growth method, and the magnetic nanoparticles are prepared. The composite magnetic polystyrene microspheres with high magnetic content, good magnetic responsiveness and superparamagnetism are synthesized; finally, functional groups are introduced to the surfaces of the magnetic spheres by monomers containing the functional groups through a monomer swelling polymerization method, and the prepared magnetic porous microspheres have the advantages of uniform particle size, small coefficient of variation and large specific surface area, and can be better combined with antigens and antibodies, so that in-vitro diagnostic function detection such as nucleic acid extraction and chemiluminescence is carried out.

The invention discloses an optical instrument based on multifunctional fluorescence chemiluminescence imaging, and belongs to the technical field of optical instruments. An optical instrument based on multifunctional fluorescence chemiluminescence imaging comprises a fluorescence chemiluminescence imaging instrument, a box door is movably installed on the lower portion of the fluorescence chemiluminescence imaging instrument, a packaging plate is movably installed in the box door, and a sealing gasket is fixedly connected to the side face of the packaging plate. The packaging plate is pushed by the telescopic spring, so that the sealing gasket on the side face of the packaging plate and the sealing frame are sealed, the sealing effect of the sample chamber is improved, when the box door is opened, the sample table slides out synchronously, the sample table can stretch out conveniently and automatically, when the box door is closed, the sample table shrinks synchronously, and convenience in sample placement is improved; the photoelectric detector detects that the external light source and the buzzer begin to buzz, and when the box door is closed, the sample box has no external light source, and the buzzer stops buzzing, so that the light source in the sample chamber is monitored, and the imaging effect is prevented from being influenced.

Kits containing a multiplexed chemiluminescent detection system and microfluidics devices and methods for detecting the presence and / or concentration of anti-SARS-CoV-2 antibodies in a sample are disclosed. The kits, microfluidics devices, and methods utilize singlet oxygen-activatable chemiluminescent compounds in combination with two or more fluorescent molecules that emit light at different wavelengths. In certain non-limiting embodiments, the kits, microfluidics devices, and methods can distinguish between anti-SARS-CoV-2 antibodies generated in response to vaccination from anti-SARS-CoV-2 antibodies generated in response to infection.

The invention discloses a method for detecting multiple biomarkers based on a nano-enzyme chemiluminescence technology, and the method comprises the following steps: preparing iron oxide nano-particles as a nano-enzyme core, and coating the surfaces of the nano-particles with substrate molecules to form a nano-enzyme-substrate compound; mixing and incubating the nano enzyme-substrate compound and a sample to be detected, adding a hydrogen peroxide solution, transferring to a microplate, and collecting a chemiluminescence signal by using a microplate reader; extracting characteristic parameters including peak value luminous intensity, peak reaching time, half-peak width, rising rate, attenuation rate, integral intensity and / or wavelength ratio in the collected luminous curve, wherein the characteristic parameters comprise the peak value luminous intensity, the peak reaching time, the half-peak width, the rising rate, the attenuation rate and the integral intensity; and constructing and training a multi-layer neural network model so as to predict the concentration of the multiple biomarkers based on the characteristic parameters of the sample data. By means of the scheme, multiple biomarkers can be detected at the same time, and the detection accuracy is improved.

The invention discloses a preparation method and application of an In2O3-Co3O4 heterostructure material, an MOFs-MOFs heterojunction takes In-MOFs as a subject and ZIF-67 as an object, and epitaxial growth of an MOFs structure is realized. And the sensor is applied to ultra-sensitive gas sensing detection, so that acetoin detection in a low-power-consumption mode is realized. The constructed sensor has the characteristics of high sensitivity, high response and recovery speed, good selectivity and the like. The unique MOFs-MOFs structure increases the adsorption active sites of the composite material, and is beneficial to the improvement of the gas sensing performance. The successful preparation of the material provides a new strategy for reasonable preparation of MOFs derivatives. Technical reference is also provided for related chemical sensors such as electrochemiluminescence sensors and electrochemical sensors, and the method has wide potential use value.

The invention discloses a gold nanocluster electrogenerated chemiluminescence probe which is a multifunctional gold nanocluster obtained by taking a 2-sulfydryl-1, 3, 4-thiadiazole ligand as a reducing agent or a protective agent. Comprising a solid-phase probe with a gold cluster modified on an electrode; or the gold cluster is independent of the electrode and is a liquid-phase probe dissolved in the electrolyte during use. The obtained electrogenerated chemiluminescence gold nanocluster probe can generate an electrogenerated chemiluminescence signal under the condition of no co-reactant, and is relatively low in luminescence potential, high in quantum yield and good in biocompatibility.